DUSLX
Price
$40.36
Change
+$0.23 (+0.57%)
Updated
Jun 26 closing price
Net Assets
3.69B
VIGRX
Price
$223.21
Change
+$1.89 (+0.85%)
Updated
Jun 26 closing price
Net Assets
293.94B
Interact to see
Advertisement

DUSLX vs VIGRX

Header iconDUSLX vs VIGRX Comparison
Open Charts DUSLX vs VIGRXBanner chart's image
DFA US Large Cap Growth Instl
Price$40.36
Change+$0.23 (+0.57%)
VolumeN/A
Net Assets3.69B
Vanguard Growth Index Investor
Price$223.21
Change+$1.89 (+0.85%)
VolumeN/A
Net Assets293.94B
DUSLX vs VIGRX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DUSLX vs. VIGRX commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DUSLX is a StrongBuy and VIGRX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 294B vs. DUSLX (3.69B). DUSLX pays higher dividends than VIGRX: DUSLX (0.99) vs VIGRX (0.35). DUSLX was incepted earlier than VIGRX: DUSLX (13 years) vs VIGRX (33 years). DUSLX (0.18) is less costly to investors than VIGRX (0.17). DUSLX (11.00) and VIGRX (11.00) have comparable annual turnover. DUSLX has a lower initial minimum investment than VIGRX: DUSLX (0) vs VIGRX (3000). VIGRX annual gain was more profitable for investors over the last year : 14.21 vs. DUSLX (11.06). VIGRX return over 5 years is better than : 119.51 vs. DUSLX (84.00).
DUSLXVIGRXDUSLX / VIGRX
Total Expense Ratio0.180.17106%
Annual Report Gross Expense Ratio0.180.17106%
Fund Existence13 years33 years-
Gain YTD4.9394.747104%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets3.69B294B1%
Annual Yield % from dividends0.990.35287%
Returns for 1 year11.0614.2178%
Returns for 3 years55.8784.7166%
Returns for 5 years84.00119.5170%
Returns for 10 years186.57305.2061%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CYTK33.910.80
+2.42%
Cytokinetics
DB29.950.67
+2.29%
Deutsche Bank Aktiengesellschaft
PCB20.820.35
+1.71%
PCB Bancorp
BCSF14.970.15
+1.01%
Bain Capital Specialty Finance
IGC0.31N/A
+0.81%
IGC Pharma